The University of Oxford and SomaLogic announce wide ranging agreement for discovery

(University of Oxford) University of Oxford and SomaLogic announced agreement to undertake collaborative projects that will employ SomaLogic's proprietary SOMAmer® reagents and SOMAscan® assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions. The agreement also includes the build-out of a SOMAscan assay service laboratory at Oxford under the direction of SomaLogic personnel.